| Dr Brian Nicholson Mathews, MD | |
|
3601 Cci Dr Nw, Huntsville, AL 35805-2606 | |
| (256) 705-4224 | |
| (256) 705-4135 |
| Full Name | Dr Brian Nicholson Mathews |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 24 Years |
| Location | 3601 Cci Dr Nw, Huntsville, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841210713 | NPI | - | NPPES |
| 009912681 | Medicaid | AL | |
| P00637786 | Other | AL | RR MEDICARE NUMBER |
| 510-50070 | Other | AL | BCBS OF ALABAMA |
| CA0084 | Other | AL | RR MEDICARE |
| 009912720 | Medicaid | AL | |
| 528701110 | Medicaid | AL | |
| 51536545 | Other | BLUE CROSS OF ALABAMA | |
| 51545053 | Other | AL | BCBS OF ALABAMA |
| 009940536 | Medicaid | AL | |
| 51545055 | Other | AL | BCBS OF ALABAMA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 00024285 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Huntsville Hospital | Huntsville, AL | Hospital |
| Athens Limestone Hospital | Athens, AL | Hospital |
| Crestwood Medical Center | Huntsville, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oncology Specialties, P.c. | 1254328495 | 69 |
News Archive
NuGEN Technologies Inc, a pace-setter in nucleic acid sample preparation, announces its entrance into the DNA market today with the Ovation WGA System, a linear, remarkably reliable, and more robust solution to whole genome amplification.
The U.S. Food and Drug Administration (FDA) has approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood disorder that can lead to disability and premature death.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that a third multi-center Phase 3 clinical study of Lymphoseek (NEO3-09) has received investigational review board approval and begun enrollment of subjects diagnosed with breast cancer or melanoma.
Researchers at Linköping University have made a discovery that could contribute to developing new vaccines and treatment alternatives for tuberculosis in the future. The results have been published in Scientific Reports, a sister journal to the highly respected periodical Nature.
Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.
› Verified 8 days ago
| Entity Name | Oncology Specialties, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669425716 PECOS PAC ID: 1254328495 Enrollment ID: O20040428001467 |
News Archive
NuGEN Technologies Inc, a pace-setter in nucleic acid sample preparation, announces its entrance into the DNA market today with the Ovation WGA System, a linear, remarkably reliable, and more robust solution to whole genome amplification.
The U.S. Food and Drug Administration (FDA) has approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood disorder that can lead to disability and premature death.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that a third multi-center Phase 3 clinical study of Lymphoseek (NEO3-09) has received investigational review board approval and begun enrollment of subjects diagnosed with breast cancer or melanoma.
Researchers at Linköping University have made a discovery that could contribute to developing new vaccines and treatment alternatives for tuberculosis in the future. The results have been published in Scientific Reports, a sister journal to the highly respected periodical Nature.
Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Nicholson Mathews, MD Po Box 18428, Huntsville, AL 35804-8428 Ph: (256) 705-4224 | Dr Brian Nicholson Mathews, MD 3601 Cci Dr Nw, Huntsville, AL 35805-2606 Ph: (256) 705-4224 |
News Archive
NuGEN Technologies Inc, a pace-setter in nucleic acid sample preparation, announces its entrance into the DNA market today with the Ovation WGA System, a linear, remarkably reliable, and more robust solution to whole genome amplification.
The U.S. Food and Drug Administration (FDA) has approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood disorder that can lead to disability and premature death.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that a third multi-center Phase 3 clinical study of Lymphoseek (NEO3-09) has received investigational review board approval and begun enrollment of subjects diagnosed with breast cancer or melanoma.
Researchers at Linköping University have made a discovery that could contribute to developing new vaccines and treatment alternatives for tuberculosis in the future. The results have been published in Scientific Reports, a sister journal to the highly respected periodical Nature.
Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.
› Verified 8 days ago
Dr. Ankur Jindal, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 201 Sivley Rd Sw, Suite 440, Huntsville, AL 35801 Phone: 256-265-0780 Fax: 256-265-0781 | |
Dr. Michael Frederick Donze Jr., D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 Sivley Rd Sw, Huntsville, AL 35801 Phone: 256-801-6047 | |
Tarun Kukkadapu, MBBS Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1104 Monroe St Sw, Huntsville, AL 35801 Phone: 256-265-5864 Fax: 256-265-5865 | |
Jennifer L. Kiessling, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4601 Whitesburg Dr Se, Suite 201, Huntsville, AL 35802 Phone: 256-880-1050 Fax: 256-213-4681 | |
Zaid Al-rufaye, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 301 Governors Dr Sw Rm 396, Huntsville, AL 35801 Phone: 256-551-4652 | |
Mr. Jesse Dewayne Faulk, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 301 Governors Dr Sw, Huntsville, AL 35801 Phone: 256-536-5511 | |
Rami Hawari, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 420 Lowell Dr Se, Suite 204, Huntsville, AL 35801 Phone: 256-536-9031 Fax: 256-539-4240 |